Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the AACR Annual Meeting 2023 2023-03-21 08:00
Saudi's Space Mission will be for the Benefit of Science 2023-03-21 00:31
Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform at the 4th Annual RNAi-Based Therapeutics Summit 2023-03-20 23:27
Transcenta Holding Limited (6628.HK) to Hold 2022 Annual Results Release Conference Call 2023-03-20 21:12
Guo Guangchang Stresses Healthy Corporate Development and Expresses Full Confidence in the Future 2023-03-20 17:12
ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS 2023-03-20 15:22
Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting 2023-03-20 15:20
Izokibep Phase 2b/3 Hidradenitis Suppurative Data Presented at the 2023 American Academy of Dermatology Annual Meeting 2023-03-20 08:41
AMGEN AND NSG BIOLABS ANNOUNCE ALBATROZ THERAPEUTICS AS WINNER OF FIRST AMGEN GOLDEN TICKET IN SINGAPORE 2023-03-20 08:00
YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ 2023-03-17 04:30
Angel Yeast Showcases Latest Product Innovations at Food Ingredients China 2023 2023-03-16 20:16
Alphamab Oncology Announces the First Patient Dosed in the Phase I Trial of Anti-HER2 bispecific ADC JSKN003 2023-03-16 09:58
Ark Biopharmaceutical and Calibr, a Division of Scripps Research, Announce Co-development Collaboration on AK0705, a Potential First-in-Class Drug for Treating a Broad Spectrum of Respiratory Diseases, Including COPD 2023-03-16 07:50
Everest Medicines to Announce Full-Year 2022 Financial Results on March 31, 2023 2023-03-15 20:45
Hummingbird Bioscience to Present Two Posters on HER3-Targeting Therapeutics at American Association for Cancer Research (AACR) Meeting 2023 2023-03-15 18:30
Alphamab Oncology to Present the Preclinical Results of PD-L1/OX40 Bispecific Antibody KN052 at AACR 2023 2023-03-15 10:06
Illumina launches its first product enabling long- and short-read sequencing on one instrument 2023-03-15 08:00
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION 2023-03-15 04:01
Ajinomoto Bio-Pharma Services Awarded Three 'CDMO Leadership Awards' 2023-03-14 20:05
Antengene Announces IND Approval for the Phase I CLINCH Trial of ATG-022 (Claudin 18.2 ADC) for the Treatment of Advanced or Metastatic Solid Tumors in China 2023-03-14 12:29
1 42 43 44 45 46 212